TELA Bio, Inc. (TELA)
0.8301
+0.01
(+1.05%)
USD |
NASDAQ |
Sep 08, 16:00
0.85
+0.02
(+2.40%)
Pre-Market: 20:00
TELA Bio Shareholders Equity (Quarterly) : -15.87M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.87M |
| March 31, 2026 | -5.201M |
| December 31, 2025 | 6.313M |
| September 30, 2025 | 1.557M |
| June 30, 2025 | 9.184M |
| March 31, 2025 | 18.12M |
| December 31, 2024 | 28.46M |
| September 30, 2024 | -6.272M |
| June 30, 2024 | 2.87M |
| March 31, 2024 | 14.38M |
| December 31, 2023 | 18.88M |
| September 30, 2023 | 30.55M |
| June 30, 2023 | 40.00M |
| March 31, 2023 | 3.141M |
| December 31, 2022 | 14.30M |
| September 30, 2022 | 23.30M |
| Date | Value |
|---|---|
| June 30, 2022 | -1.542M |
| March 31, 2022 | 10.04M |
| December 31, 2021 | 20.10M |
| September 30, 2021 | 27.73M |
| June 30, 2021 | 34.96M |
| March 31, 2021 | 41.69M |
| December 31, 2020 | 49.03M |
| September 30, 2020 | 56.33M |
| June 30, 2020 | 63.40M |
| March 31, 2020 | 24.23M |
| December 31, 2019 | 30.96M |
| September 30, 2019 | -15.02M |
| June 30, 2019 | -12.68M |
| March 31, 2019 | |
| December 31, 2018 | -13.71M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.74M |
| Total Liabilities (Quarterly) | 75.60M |
| Debt to Equity Ratio | -3.568 |
| Current Ratio | 2.991 |
| Net Debt Paydown Yield | -8.81% |